Psyence Biomed Enters into Agreement to Acquire Stake in PsyLabs
September 19, 2024 07:30 ET
|
Psyence Biomedical Ltd.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed" or the "Company") today announced that it has entered into a conditional share sale agreement...
Shock Top Announces its Official Craft Beer Sponsorship of University of Missouri Athletics
September 19, 2024 07:12 ET
|
Tilray Brands, Inc.
Shock Top is proud to contribute to the collegiate experience by promoting a culture of inclusivity, support, and pride that transcends the game.
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
September 19, 2024 07:00 ET
|
Lifecore Biomedical, Inc.
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for...
Arqit Quantum Inc. Announces 25:1 Reverse Share Split
September 19, 2024 07:00 ET
|
Arqit
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a leader in quantum safe encryption, today announces that, following approval by the...
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
September 19, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
Join Mobilicom’s Exclusive Live Investor Webinar and Q&A Session on September 25
September 19, 2024 07:00 ET
|
Mobilicom Limited
SHOHAM, Israel, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, is pleased to invite investors to a...
European Wax Center Announces Commercial and Operational Updates Including New Partnership with Dolabra Digital
September 19, 2024 07:00 ET
|
European Wax Center, Inc.
PLANO, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Today, European Wax Center, Inc. (NASDAQ: EWCZ) (the “Company” or “European Wax Center”), the largest and fastest-growing franchisor and operator of...
ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024
September 19, 2024 07:00 ET
|
ACELYRIN, INC.
LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative...
BioXcel Therapeutics Announces Clinical Prioritization and Update on BXCL501 Late-Stage Programs for Agitation
September 19, 2024 07:00 ET
|
BioXcel Therapeutics
Recently initiated SERENITY At-Home pivotal Phase 3 trial for agitation associated with bipolar disorders or schizophrenia Submitted protocol to FDA for TRANQUILITY In-Care pivotal Phase 3 trial...
FactSet Reports Results for Fourth Quarter 2024
September 19, 2024 07:00 ET
|
FactSet Research Systems Inc.
Q4 GAAP revenues of $562.2 million, up 4.9% from Q4 2023.Organic Q4 ASV plus professional services of $2,272.8 million, up 4.8% year over year.Q4 GAAP operating margin of 22.7%, up approximately 110...